REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $420,985 | -35.6% | 15,209 | -44.6% | 0.02% | -54.3% |
| Q4 2022 | $654,002 | -47.4% | 27,456 | -57.0% | 0.04% | -35.2% |
| Q2 2022 | $1,243,000 | -28.2% | 63,800 | -5.9% | 0.05% | -27.0% |
| Q1 2022 | $1,730,000 | +187.4% | 67,800 | +183.7% | 0.07% | +94.7% |
| Q4 2021 | $602,000 | +8.5% | 23,900 | +70.5% | 0.04% | -59.6% |
| Q4 2020 | $555,000 | – | 14,016 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |